Abstract
Abstract
This study presents follow-up of a prior study of patients with chronic symptomatic oral chronic graft-versus-host-disease (cGVHD) managed with photobiomodulation therapy (PBM therapy for 1 month. Here, we report long-term follow-up of a series of patients where PBM therapy in patients with oral cGVHD for maintenance follows the initial period of PBM therapy for continuing management.
Patients and methods
We report continuing follow-up of 7 cases of oral cGVHD that were treated with PBM therapy. PBM therapy was continued in these patients with the goal of determining the best management schedule of PBM to maintain or improve control of each patient’s symptoms and signs of oral cGVHD.
Results
Oral sensitivity and mucosal changes of cGVHD were controlled with a continuing schedule of PBM therapy of up to 6–8-week treatment intervals in patients with continuing GVHD. These findings suggest that PBM therapy represents an additional approach for continuing management of oral cGVHD and that the frequency of treatment should be individualized for each patient to provide best control of oral findings. In one case weekly PBM treatment was continued, while in others, management on a monthly or bimonthly basis was associated with control of the oral condition. PBM may be individualized and provided based upon best control of the symptoms and signs of oral GVHD.
Similar content being viewed by others
References
Meier JK, Wolff D, Pavletic S, Greinix H, Gosau M, Bertz H, Lee SJ, Lawitschka A, Elad S, International Consensus Conference on Clinical Practice in cGVHD (2011) Oral chronic graft-versus-host disease: report from the international consensus conference on clinical practice in cGVHD. Clin Oral Invest 15(2):127–139
Epstein JB, Raber-Durlacher JE, Lill M, Linhares YP et al (2017) Photobiomodulation therapy in management of chronic oral graft-versus-host-disease. Support Care Cancer 25(2):357–364
Imanguli MM, Atkinson JC, Harvey KE, Hoehn GT, Ryu OH, Wu T, Kingman A, Barrett AJ, Bishop MR, Childs RW, Fowler DH, Pavletic SZ, Hart TC (2007) Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation. Exp Hematol 35(2):184–192
Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L (2014) Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One 9(9):e107418
Stoopler ET (2013) Management of oral chronic graft-versus-host disease. Journal 79:d37
Chow R, Armati P, Laakso EL, Bjordal JM, Baxter GD (2011) Inhibitory effects of laser irradiation on peripheral mammalian nerves and relevance to analgesic effects: a systematic review. Photomed Laser Surg 29(6):365–381
Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B et al (2013) Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer 21(1):333–341
Woodruff LD, Bounkeo JM, Brannon WM, Dawes KS, Barham CD, Waddell DL, Enwemeka CS (2001) The efficacy of laser therapy in wound repair: a meta-analysis of the literature. Photomed Laser Surg 22(3):241–247
Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S et al (2016) Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer 24(6):2781–2792
Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Elad S, Hamblin MR et al (2016) Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols. Support Care Cancer 24(6):2793–2805
Fillipin LI, Mauriz JL, Vedovelli K, Moreira AJ, Zettler CG, Lech O, Marroni NP, González-Gallego J (2005) Low-level laser therapy (LLLT) prevents oxidative stress and reduces fibrosis in rat traumatized Achilles tendon. Lasers SurgMed 37(4):293–300
Dillenburg CS, Martins MA, Munerato MC et al (2014) Efficacy of laser phototherapy in comparison to topical clobetasol for the treatment of oral lichen planus: a randomized controlled trial. J Biomed Opt 19:068002
Othman NA, Shaker OG, Elshenawy HM et al (2016) The effect of diode laser and topical steroid on serum level of TNF alpha in oral lichen planus patients. J Clin Exp Dent 8:e566–e570
Akram Z, Adbduljabbar T, Vohra F et al (2018) Efficacy of low-level laser therapy compared to steroid therapy in the treatment of oral lichen planus: A systematic review. J Oral Pathol Med 47:11–17
Al-Maweri SA, Asjraf S, Kalakonda B et al (2018) Efficacy of photodynamic therapy in the treatment of symptomatic oral lichen planus: a systematic review. J Oral Pathol Med 47:326–332
Lee SJ (2017) Classification systems for chronic graft-versus-host disease. Blood 129(1):30–37
Elad S, Arany P, Bensadoun RJ, Epstein JB et al (2018) Photobiomodulation therapy in the management of oral mucositis: Search for the optimal clinical treatment parameters. Support Care Cancer 26:3319–3321
Zadik Y, Arany PR, Fregnani ER, Bossi P, Antunes HS, Bensadoun R-J et al (2019 Oct) Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27(10):3969–3983
Cafaro A, Arduino PG, Massolini G, Romagnoli E, Broccoletti R (2014) Clinical evaluation of the efficiency of low-level laser therapy for oral lichen planus: a prospective case series. Lasers Med Sci 29(1):185–190
Barros de Ameida E, Da Mota Vasconcelos Brasil C, Serpa M, Correia A, Da Rosa M, De Castro J (2014) Low-level laser therapy in oral graft-versus-host disease. Oral Surg Oral Med Oral Pathol Oral Radiol 117:e214–e215
Cafaro A, Cambino A, Conrotto D, Broccoletti R, Arduino P (2014) Low level laser therapy in oral graft versus host disease; a case report. Ann Stomatol 2014(suppl 3):2 14
Chor A, de Azevedo AM, Maiolino A, Nucci M (2004) Successful treatment of oral lesions of chronic lichenoid graft-vs.-host disease by the addition of low-level laser therapy to systemic immunosuppression. Europ J Haematol 72(3):222–224
Chor A, Sotero Caio AB, de Azevedo AM (2001) The irreplaceable image: amelioration of oral mucosal lesions of acute graft-versus-host disease by low-level laser therapy. Haematologica 86(12):1321
Epstein JB, Raber-Durlacher JE, Huysmans MC, Schoordijk MCE, Cheng JE, Bensadoun RJ, Arany PR (2018) Photobiomodulation therapy alleviates tissue fibroses associated with chronic graft-versus-host disease: two case reports and putative anti-fibrotic roles of TGF-B. Photomed Laser Surg 36(2):92–99
Loncar B, Stipetic MM, Baricevic M, Risovic D (2011) The effect of low-level laser therapy on salivary glands in patients with xerostomia. Photomed Laser Surg 29(3):171–175
Vidovic Juras D, Lukac J, Cekic-Arambasin A, Vidovic A, Canjuga I, Sikora M et al (2010) Effects of low-level laser treatment on mouth dryness. Collegium Antropologicum 34(3):1039–1043
Plavnik LM, De Crosa ME, Malberti AI (2003) Effect of low-power radiation (helium/neon) upon submandibulary glands. J Clin Laser Med Surg 21(4):219–225
Takeda Y (1988) Irradiation effect of low-energy laser on rat submandibular salivary gland. J O Pathol 17(2):91–94
Cowen D, Tardieu C, Schubert M, Peterson D, Resbeut M, Faucher C, Franquin JC (1997) Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 38(4):697–703
Arbabi-Kalati F, Arbabi-Kalati F, Moridi T (2013) Evaluation of the effect of low level laser on prevention of chemotherapy-induced mucositis. Acta Medica Iranica 51(3):157–162
Oton-Leite AF, Elias LS, Morais MO, Pinezi JC, Leles CR, Silva MA, Mendonca EF (2013) Effect of low level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy. Spec CareDent 33(6):294–300
Mawardi H, Elad S, Correa ME, Stevenson K, Woo SB, Almazrooa S, Haddad R, Antin JH, Soiffer R, Treister N (2011) Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplant 46(6):884–891
Acknowledgments
The authors acknowledge James Carroll, THOR Photomedicine Ltd., for providing PBM therapy devices and suggestions on PBM therapy parameters used in this case series.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Epstein, J.B., Raber-Durlacher, J.E., Epstein, G.L. et al. Chronic oral graft-versus-host disease: induction and maintenance therapy with photobiomodulation therapy. Support Care Cancer 29, 1387–1394 (2021). https://doi.org/10.1007/s00520-020-05626-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-020-05626-3